{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:13:21Z","timestamp":1717460001917},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00393-023-01472-w","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T18:01:54Z","timestamp":1706119314000},"page":"376-386","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["H\u00e4mophagozytische Lymphohistiozytose und Makrophagenaktivierungssyndrom","Hemophagocytic lymphohistiocytosis and macrophage activation syndrome"],"prefix":"10.1007","volume":"83","author":[{"given":"Nikolas","family":"Ruffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Kosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Weisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"K\u00f6tter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Krusche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"issue":"4","key":"1472_CR1","doi-asserted-by":"publisher","first-page":"101515","DOI":"10.1016\/j.berh.2020.101515","volume":"34","author":"G Griffin","year":"2020","unstructured":"Griffin\u00a0G, Shenoi\u00a0S, Hughes\u00a0GC (2020) Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol 34(4):101515. https:\/\/doi.org\/10.1016\/j.berh.2020.101515","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"Suppl 6","key":"1472_CR2","doi-asserted-by":"publisher","first-page":"vi23","DOI":"10.1093\/rheumatology\/kez379","volume":"58","author":"M Hutchinson","year":"2019","unstructured":"Hutchinson\u00a0M, Tattersall\u00a0RS, Manson\u00a0JJ (2019) Haemophagocytic lymphohisticytosis\u2014an underrecognized hyperinflammatory syndrome. Rheumatology 58(Suppl 6):vi23\u2013vi30. https:\/\/doi.org\/10.1093\/rheumatology\/kez379","journal-title":"Rheumatology"},{"issue":"10","key":"1472_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/ard-2023-224123","volume":"82","author":"B Shakoory","year":"2023","unstructured":"Shakoory\u00a0B, Geerlinks\u00a0A, Wilejto\u00a0M et\u00a0al (2023) The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS). Ann Rheum Dis 82(10):1271\u20131285. https:\/\/doi.org\/10.1136\/ard-2023-224123","journal-title":"Ann Rheum Dis"},{"key":"1472_CR4","doi-asserted-by":"publisher","first-page":"1210041","DOI":"10.3389\/fimmu.2023.1210041","volume":"14","author":"A Chinnici","year":"2023","unstructured":"Chinnici\u00a0A, Beneforti\u00a0L, Pegoraro\u00a0F et\u00a0al (2023) Approaching hemophagocytic lymphohistiocytosis. Front Immunol 14:1210041. https:\/\/doi.org\/10.3389\/fimmu.2023.1210041","journal-title":"Front Immunol"},{"issue":"1","key":"1472_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/rheumatology\/key006","volume":"58","author":"SJ Carter","year":"2019","unstructured":"Carter\u00a0SJ, Tattersall\u00a0RS, Ramanan\u00a0AV (2019) Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment. Rheumatology 58(1):5\u201317. https:\/\/doi.org\/10.1093\/rheumatology\/key006","journal-title":"Rheumatology"},{"issue":"11","key":"1472_CR6","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1111\/apa.16013","volume":"110","author":"M Meeths","year":"2021","unstructured":"Meeths\u00a0M, Bryceson\u00a0YT (2021) Genetics and pathophysiology of haemophagocytic lymphohistiocytosis. Acta Paediatr 110(11):2903\u20132911. https:\/\/doi.org\/10.1111\/apa.16013","journal-title":"Acta Paediatr"},{"issue":"17","key":"1472_CR7","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1182\/blood-2016-03-700609","volume":"127","author":"M Meeths","year":"2016","unstructured":"Meeths\u00a0M, Bryceson\u00a0YT (2016) HLH susceptibility: genetic lesions add up. Blood 127(17):2051\u20132052. https:\/\/doi.org\/10.1182\/blood-2016-03-700609","journal-title":"Blood"},{"issue":"1","key":"1472_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00018-011-0835-y","volume":"69","author":"E Sieni","year":"2012","unstructured":"Sieni\u00a0E, Cetica\u00a0V, Mastrodicasa\u00a0E et\u00a0al (2012) Familial hemophagocytic lymphohistiocytosis: a\u00a0model for understanding the human machinery of cellular cytotoxicity. Cell Mol Life Sci 69(1):29\u201340. https:\/\/doi.org\/10.1007\/s00018-011-0835-y","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"1472_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/01.bor.0000381996.69261.71","volume":"22","author":"AA Grom","year":"2010","unstructured":"Grom\u00a0AA, Mellins\u00a0ED (2010) Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol 22(5):561\u2013566. https:\/\/doi.org\/10.1097\/01.bor.0000381996.69261.71","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"1472_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","volume":"49","author":"SJ Vastert","year":"2010","unstructured":"Vastert\u00a0SJ, Van Wijk\u00a0R, D\u2019urbano\u00a0LE et\u00a0al (2010) Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology 49(3):441\u2013449. https:\/\/doi.org\/10.1093\/rheumatology\/kep418","journal-title":"Rheumatology"},{"key":"1472_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.07.023","author":"C Bloch","year":"2023","unstructured":"Bloch\u00a0C, Jais\u00a0JP, Gil\u00a0M et\u00a0al (2023) Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants. J\u00a0Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2023.07.023","journal-title":"J Allergy Clin Immunol"},{"issue":"15","key":"1472_CR12","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","volume":"118","author":"MB Jordan","year":"2011","unstructured":"Jordan\u00a0MB, Allen\u00a0CE, Weitzman\u00a0S et\u00a0al (2011) How I treat hemophagocytic lymphohistiocytosis. Blood 118(15):4041\u20134052. https:\/\/doi.org\/10.1182\/blood-2011-03-278127","journal-title":"Blood"},{"issue":"1","key":"1472_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13023-021-01790-9","volume":"16","author":"L Liu","year":"2021","unstructured":"Liu\u00a0L, Cui\u00a0Y, Zhou\u00a0Q et\u00a0al (2021) Hemophagocytic lymphohistiocytosis during pregnancy: a\u00a0review of the literature in epidemiology, pathogenesis, diagnosis and treatment. Orphanet J Rare Dis 16(1):281. https:\/\/doi.org\/10.1186\/s13023-021-01790-9","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"1472_CR14","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2665-9913(20)30096-5","volume":"2","author":"P Mehta","year":"2020","unstructured":"Mehta\u00a0P, Cron\u00a0RQ, Hartwell\u00a0J et\u00a0al (2020) Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol 2(6):e358\u2013e367. https:\/\/doi.org\/10.1016\/S2665-9913(20)30096-5","journal-title":"Lancet Rheumatol"},{"key":"1472_CR15","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1016\/j.clml.2017.02.017","volume":"17","author":"ZK Otrock","year":"2017","unstructured":"Otrock\u00a0ZK, Daver\u00a0N, Kantarjian\u00a0HM et\u00a0al (2017) Diagnostic challenges of hemophagocytic lymphohistiocytosis. Clin Lymphoma Myeloma Leuk 17:S105\u2013S110. https:\/\/doi.org\/10.1016\/j.clml.2017.02.017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"17","key":"1472_CR16","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1182\/blood.2020009499","volume":"137","author":"V Chaturvedi","year":"2021","unstructured":"Chaturvedi\u00a0V, Marsh\u00a0RA, Zoref-Lorenz\u00a0A et\u00a0al (2021) T\u2011cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis. Blood 137(17):2337\u20132346. https:\/\/doi.org\/10.1182\/blood.2020009499","journal-title":"Blood"},{"issue":"3","key":"1472_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1182\/blood.2021013549","volume":"140","author":"A De Matteis","year":"2022","unstructured":"De Matteis\u00a0A, Colucci\u00a0M, Rossi\u00a0MN et\u00a0al (2022) Expansion of CD4dimCD8+ T\u00a0cells characterizes macrophage activation syndrome and other secondary HLH. Blood 140(3):262\u2013273. https:\/\/doi.org\/10.1182\/blood.2021013549","journal-title":"Blood"},{"issue":"9","key":"1472_CR18","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet\u00a0L, Galicier\u00a0L, Lambotte\u00a0O et\u00a0al (2014) Development and validation of the HScore, a\u00a0score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 66(9):2613\u20132620. https:\/\/doi.org\/10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"issue":"25","key":"1472_CR19","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","volume":"130","author":"E Bergsten","year":"2017","unstructured":"Bergsten\u00a0E, Horne\u00a0A, Arico\u00a0M et\u00a0al (2017) Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood 130(25):2728\u20132738. https:\/\/doi.org\/10.1182\/blood-2017-06-788349","journal-title":"Blood"},{"issue":"2","key":"1472_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/ejh.13779","volume":"109","author":"L Bilston","year":"2022","unstructured":"Bilston\u00a0L, Croden\u00a0J, Taparia\u00a0M et\u00a0al (2022) Validation of the HScore and the HLH-2004 diagnostic criteria for the diagnosis of hemophagocytic lymphohistiocytosis in a\u00a0multicenter cohort. Eur J Haematol 109(2):129\u2013137. https:\/\/doi.org\/10.1111\/ejh.13779","journal-title":"Eur J Haematol"},{"issue":"3","key":"1472_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/jnen\/nlz001","volume":"78","author":"C Klein","year":"2019","unstructured":"Klein\u00a0C, Kleinschmidt-Demasters\u00a0BK, Liang\u00a0X et\u00a0al (2019) A review of neuropathological features of familial and adult hemophagocytic lymphohistiocytosis. J\u00a0Neuropathol Exp Neurol 78(3):197\u2013208. https:\/\/doi.org\/10.1093\/jnen\/nlz001","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"1472_CR22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/his.14591","volume":"80","author":"A Kikuchi","year":"2022","unstructured":"Kikuchi\u00a0A, Singh\u00a0K, Gars\u00a0E et\u00a0al (2022) Pathology updates and diagnostic approaches to haemophagocytic lymphohistiocytosis. Histopathology 80(4):616\u2013626. https:\/\/doi.org\/10.1111\/his.14591","journal-title":"Histopathology"},{"issue":"3","key":"1472_CR23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/1751143719893865","volume":"21","author":"K Bauchmuller","year":"2020","unstructured":"Bauchmuller\u00a0K, Manson\u00a0JJ, Tattersall\u00a0R et\u00a0al (2020) Haemophagocytic lymphohistiocytosis in adult critical care. J\u00a0Intensive Care Soc 21(3):256\u2013268. https:\/\/doi.org\/10.1177\/1751143719893865","journal-title":"J Intensive Care Soc"},{"issue":"4","key":"1472_CR24","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1378\/chest.11-0619","volume":"140","author":"RA Raschke","year":"2011","unstructured":"Raschke\u00a0RA, Garcia-Orr\u00a0R (2011) Hemophagocytic lymphohistiocytosis: a\u00a0potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults. Chest 140(4):933\u2013938. https:\/\/doi.org\/10.1378\/chest.11-0619","journal-title":"Chest"},{"issue":"26","key":"1472_CR25","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1182\/bloodadvances.2017012310","volume":"1","author":"A Hayden","year":"2017","unstructured":"Hayden\u00a0A, Lin\u00a0M, Park\u00a0S et\u00a0al (2017) Soluble interleukin\u20112 receptor is a\u00a0sensitive diagnostic test in adult HLH. Blood Adv 1(26):2529\u20132534. https:\/\/doi.org\/10.1182\/bloodadvances.2017012310","journal-title":"Blood Adv"},{"issue":"6","key":"1472_CR26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.20102538","volume":"208","author":"EE Zoller","year":"2011","unstructured":"Zoller\u00a0EE, Lykens\u00a0JE, Terrell\u00a0CE et\u00a0al (2011) Hemophagocytosis causes a\u00a0consumptive anemia of inflammation. J\u00a0Exp Med 208(6):1203\u20131214. https:\/\/doi.org\/10.1084\/jem.20102538","journal-title":"J Exp Med"},{"key":"1472_CR27","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fimmu.2020.00524","volume":"11","author":"RD Sandler","year":"2020","unstructured":"Sandler\u00a0RD, Tattersall\u00a0RS, Schoemans\u00a0H et\u00a0al (2020) Diagnosis and Management of Secondary HLH\/MAS Following HSCT and CAR-T\u00a0Cell Therapy in Adults; A\u00a0Review of the Literature and a\u00a0Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP). Front Immunol 11:524. https:\/\/doi.org\/10.3389\/fimmu.2020.00524","journal-title":"Front Immunol"},{"issue":"23","key":"1472_CR28","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Rosee","year":"2019","unstructured":"La Rosee\u00a0P, Horne\u00a0A, Hines\u00a0M et\u00a0al (2019) Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 133(23):2465\u20132477. https:\/\/doi.org\/10.1182\/blood.2018894618","journal-title":"Blood"},{"issue":"8","key":"1472_CR29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3324\/haematol.2015.123562","volume":"100","author":"K Lehmberg","year":"2015","unstructured":"Lehmberg\u00a0K, Nichols\u00a0KE, Henter\u00a0JI et\u00a0al (2015) Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. Haematologica 100(8):997\u20131004. https:\/\/doi.org\/10.3324\/haematol.2015.123562","journal-title":"Haematologica"},{"issue":"12","key":"1472_CR30","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S1473-3099(07)70290-6","volume":"7","author":"NG Rouphael","year":"2007","unstructured":"Rouphael\u00a0NG, Talati\u00a0NJ, Vaughan\u00a0C et\u00a0al (2007) Infections associated with haemophagocytic syndrome. Lancet Infect Dis 7(12):814\u2013822. https:\/\/doi.org\/10.1016\/S1473-3099(07)70290-6","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1472_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12969-019-0309-6","volume":"17","author":"O Halyabar","year":"2019","unstructured":"Halyabar\u00a0O, Chang\u00a0MH, Schoettler\u00a0ML et\u00a0al (2019) Calm in the midst of cytokine storm: a\u00a0collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Pediatr Rheumatol Online\u00a0J 17(1):7. https:\/\/doi.org\/10.1186\/s12969-019-0309-6","journal-title":"Pediatr Rheumatol Online J"},{"issue":"9","key":"1472_CR32","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3899\/jrheum.211219","volume":"49","author":"ML Taylor","year":"2022","unstructured":"Taylor\u00a0ML, Hoyt\u00a0KJ, Han\u00a0J et\u00a0al (2022) An evidence-based guideline improves outcomes for patients with hemophagocytic lymphohistiocytosis and macrophage activation syndrome. J\u00a0Rheumatol 49(9):1042\u20131051. https:\/\/doi.org\/10.3899\/jrheum.211219","journal-title":"J Rheumatol"},{"issue":"2","key":"1472_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter\u00a0JI, Horne\u00a0A, Arico\u00a0M et\u00a0al (2007) HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124\u2013131. https:\/\/doi.org\/10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"1472_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/art.11368","volume":"49","author":"R Dhote","year":"2003","unstructured":"Dhote\u00a0R, Simon\u00a0J, Papo\u00a0T et\u00a0al (2003) Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 49(5):633\u2013639. https:\/\/doi.org\/10.1002\/art.11368","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1472_CR35","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/rheumatology\/ken342","volume":"47","author":"S Fukaya","year":"2008","unstructured":"Fukaya\u00a0S, Yasuda\u00a0S, Hashimoto\u00a0T et\u00a0al (2008) Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30\u00a0cases. Rheumatology 47(11):1686\u20131691. https:\/\/doi.org\/10.1093\/rheumatology\/ken342","journal-title":"Rheumatology"},{"issue":"Suppl 1","key":"1472_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00393-022-01276-4","volume":"81","author":"S Vordenbaumen","year":"2022","unstructured":"Vordenbaumen\u00a0S, Feist\u00a0E, Rech\u00a0J et\u00a0al (2022) DGRh-S2e-Leitlinie. Diagnostik und Therapie des adulten Still-Syndroms (AOSD). Z\u00a0Rheumatol 81(Suppl 1):1\u201320. https:\/\/doi.org\/10.1007\/s00393-022-01276-4","journal-title":"Z Rheumatol"},{"issue":"3","key":"1472_CR37","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3324\/haematol.2013.097394","volume":"99","author":"K Delavigne","year":"2014","unstructured":"Delavigne\u00a0K, Berard\u00a0E, Bertoli\u00a0S et\u00a0al (2014) Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy. Haematologica 99(3):474\u2013480. https:\/\/doi.org\/10.3324\/haematol.2013.097394","journal-title":"Haematologica"},{"issue":"3","key":"1472_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/bjh.12138","volume":"160","author":"K Lehmberg","year":"2013","unstructured":"Lehmberg\u00a0K, Ehl\u00a0S (2013) Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. Br J Haematol 160(3):275\u2013287. https:\/\/doi.org\/10.1111\/bjh.12138","journal-title":"Br J Haematol"},{"key":"1472_CR39","volume-title":"onkopedia leitlinien","author":"PG La Ros\u00e9e","year":"2020","unstructured":"La Ros\u00e9e\u00a0PG, Beutel\u00a0K, Birndt\u00a0S et\u00a0al (2020) H\u00e4mophagozytische Lymphohistiozytose (HLH). In: onkopedia leitlinien"},{"issue":"6","key":"1472_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.blre.2016.05.001","volume":"30","author":"A Hayden","year":"2016","unstructured":"Hayden\u00a0A, Park\u00a0S, Giustini\u00a0D et\u00a0al (2016) Hemophagocytic syndromes (HPss) including hemophagocytic lymphohistiocytosis (HLH) in adults: a\u00a0systematic scoping review. Blood Rev 30(6):411\u2013420. https:\/\/doi.org\/10.1016\/j.blre.2016.05.001","journal-title":"Blood Rev"},{"issue":"6","key":"1472_CR41","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/ard-2022-223739","volume":"82","author":"F De Benedetti","year":"2023","unstructured":"De Benedetti\u00a0F, Grom\u00a0AA, Brogan\u00a0PA et\u00a0al (2023) Efficacy and safety of emapalumab in macrophage activation syndrome. Ann Rheum Dis 82(6):857\u2013865. https:\/\/doi.org\/10.1136\/ard-2022-223739","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1472_CR42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","volume":"28","author":"JI Henter","year":"1997","unstructured":"Henter\u00a0JI, Arico\u00a0M, Egeler\u00a0RM et\u00a0al (1997) HLH-94: a\u00a0treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 28(5):342\u2013347. https:\/\/doi.org\/10.1002\/(SICI)1096-911X(199705)28:5%3C342::AID-MPO3%3E3.0.CO;2-H","journal-title":"Med Pediatr Oncol"},{"issue":"7","key":"1472_CR43","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","volume":"100","author":"JI Henter","year":"2002","unstructured":"Henter\u00a0JI, Samuelsson-Horne\u00a0A, Arico\u00a0M et\u00a0al (2002) Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100(7):2367\u20132373. https:\/\/doi.org\/10.1182\/blood-2002-01-0172","journal-title":"Blood"},{"issue":"1","key":"1472_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","volume":"15","author":"SS Neelapu","year":"2018","unstructured":"Neelapu\u00a0SS, Tummala\u00a0S, Kebriaei\u00a0P et\u00a0al (2018) Chimeric antigen receptor T\u2011cell therapy\u2014assessment and management of toxicities. Nat Rev Clin Oncol 15(1):47\u201362. https:\/\/doi.org\/10.1038\/nrclinonc.2017.148","journal-title":"Nat Rev Clin Oncol"},{"issue":"17","key":"1472_CR45","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","volume":"118","author":"H Trottestam","year":"2011","unstructured":"Trottestam\u00a0H, Horne\u00a0A, Arico\u00a0M et\u00a0al (2011) Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94\u00a0treatment protocol. Blood 118(17):4577\u20134584. https:\/\/doi.org\/10.1182\/blood-2011-06-356261","journal-title":"Blood"},{"issue":"4","key":"1472_CR46","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00432-020-03139-4","volume":"146","author":"S Birndt","year":"2020","unstructured":"Birndt\u00a0S, Schenk\u00a0T, Heinevetter\u00a0B et\u00a0al (2020) Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a\u00a0nationwide German registry. J\u00a0Cancer Res Clin Oncol 146(4):1065\u20131077. https:\/\/doi.org\/10.1007\/s00432-020-03139-4","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"1472_CR47","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.mayocp.2013.12.012","volume":"89","author":"SA Parikh","year":"2014","unstructured":"Parikh\u00a0SA, Kapoor\u00a0P, Letendre\u00a0L et\u00a0al (2014) Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc 89(4):484\u2013492. https:\/\/doi.org\/10.1016\/j.mayocp.2013.12.012","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"1472_CR48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5492\/wjccm.v7.i6.73","volume":"7","author":"S Kapoor","year":"2018","unstructured":"Kapoor\u00a0S, Morgan\u00a0CK, Siddique\u00a0MA et\u00a0al (2018) Intensive care unit complications and outcomes of adult patients with hemophagocytic lymphohistiocytosis: A\u00a0retrospective study of 16\u00a0cases. World J Crit Care Med 7(6):73\u201383. https:\/\/doi.org\/10.5492\/wjccm.v7.i6.73","journal-title":"World J Crit Care Med"},{"issue":"2","key":"1472_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/SHK.0000000000001048","volume":"50","author":"G Lachmann","year":"2018","unstructured":"Lachmann\u00a0G, Spies\u00a0C, Schenk\u00a0T et\u00a0al (2018) Hemophagocytic lymphohistiocytosis: potentially underdiagnosed in intensive care units. Shock 50(2):149\u2013155. https:\/\/doi.org\/10.1097\/SHK.0000000000001048","journal-title":"Shock"},{"issue":"5","key":"1472_CR50","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/BOR.0000000000000822","volume":"33","author":"P Mehta","year":"2021","unstructured":"Mehta\u00a0P, Fajgenbaum\u00a0DC (2021) Is severe COVID-19 a\u00a0cytokine storm syndrome: a\u00a0hyperinflammatory debate. Curr Opin Rheumatol 33(5):419\u2013430. https:\/\/doi.org\/10.1097\/BOR.0000000000000822","journal-title":"Curr Opin Rheumatol"},{"issue":"10229","key":"1472_CR51","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta\u00a0P, Mcauley\u00a0DF, Brown\u00a0M et\u00a0al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"1472_CR52","volume-title":"S3-Leitlinie-Empfehlungen zur Therapie von Patienten mit COVID-19","author":"S Kluge","year":"2023","unstructured":"Kluge\u00a0S, Janssens\u00a0U, Welte\u00a0T et\u00a0al (2023) S3-Leitlinie-Empfehlungen zur Therapie von Patienten mit COVID-19"},{"issue":"10236","key":"1472_CR53","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S0140-6736(20)31057-6","volume":"395","author":"DL Leverenz","year":"2020","unstructured":"Leverenz\u00a0DL, Tarrant\u00a0TK (2020) Is the HScore useful in COVID-19? Lancet 395(10236):e83. https:\/\/doi.org\/10.1016\/S0140-6736(20)31057-6","journal-title":"Lancet"},{"issue":"5","key":"1472_CR54","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1111\/bjh.16934","volume":"190","author":"H Wood","year":"2020","unstructured":"Wood\u00a0H, Jones\u00a0JR, Hui\u00a0K et\u00a0al (2020) Secondary HLH is uncommon in severe COVID-19. Br J Haematol 190(5):e283\u2013e285. https:\/\/doi.org\/10.1111\/bjh.16934","journal-title":"Br J Haematol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01472-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-023-01472-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-023-01472-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T11:04:50Z","timestamp":1717412690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-023-01472-w"}},"subtitle":["Eine multidisziplin\u00e4re Herausforderung","A multidisciplinary challenge"],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1472"],"URL":"https:\/\/doi.org\/10.1007\/s00393-023-01472-w","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"assertion":[{"value":"15 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"N.\u00a0Ruffer, R.\u00a0Kosch, K.\u00a0Weisel, I.\u00a0K\u00f6tter und M.\u00a0Krusche geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autor:innen durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient:innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}